The world

THE 2004 PROHIBITED
INTERNATIONAL
STANDARD
(update 25 November 2003)
This List shall come into effect on January 1st 2004.
THE 2004 PROHIBITED LIST
WORLD ANTI-DOPING CODE
Valid 1st January 2004
(Updated 25 November 2003)
SUBSTANCES AND METHODS
PROHIBITED IN-COMPETITION
PROHIBITED SUBSTANCES

S1. STIMULANTS

The following stimulants are prohibited, including both their optical (D- and L-)
isomers where relevant:
Adrafinil, amfepramone, amiphenazole, amphetamine, amphetaminil,
benzphetamine, bromantan, carphedon, cathine*, clobenzorex, cocaine,
dimethylamphetamine, ephedrine**, etilamphetamine, etilefrine,
fencamfamin, fenetylline, fenfluramine, fenproporex, furfenorex,
mefenorex, mephentermine, mesocarb, methamphetamine,
methylamphetamine, methylenedioxyamphetamine,
methylenedioxymethamphetamine, methylephedrine**, methylphenidate,
modafinil, nikethamide, norfenfluramine, parahydroxyamphetamine,
pemoline, phendimetrazine, phenmetrazine, phentermine, prolintane,
selegiline, strychnine, and other substances with similar chemical structure or
similar pharmacological effects***.

* Cathine is prohibited when its concentration in urine is greater than 5
micrograms per millilitre.
** Each of ephedrine and methylephedrine is prohibited when its concentration
in urine is greater than 10 micrograms per millilitre.
*** The substances included in the 2004 Monitoring Program are not considered as
Prohibited Substances.


S2. NARCOTICS

The following narcotics are prohibited:

buprenorphine, dextromoramide, diamorphine (heroin), hydromorphone,
methadone, morphine, oxycodone, oxymorphone, pentazocine, pethidine.

S3. CANNABINOIDS

Cannabinoids (e.g. hashish, marijuana) are prohibited.
S4. ANABOLIC AGENTS

Anabolic agents are prohibited.
1. Anabolic Androgenic Steroids (AAS)

a. Exogenous* AAS including but not limited to:

androstadienone, bolasterone, boldenone, boldione, clostebol, danazol,
dehydrochloromethyltestosterone, delta1-androstene-3,17-dione,
drostanolone, drostanediol, fluoxymesterone, formebolone, gestrinone, 4-
hydroxytestosterone, 4-hydroxy-19-nortestosterone, mestanolone,
mesterolone, methandienone, metenolone, methandriol,
methyltestosterone, mibolerone, nandrolone, 19-norandrostenediol,
19-norandrostenedione, norbolethone, norethandrolone, oxabolone,
oxandrolone, oxymesterone, oxymetholone, quinbolone, stanozolol,
stenbolone, 1-testosterone (delta1-dihydro-testosterone), trenbolone
and their analogues#.

b. Endogenous** AAS including but not limited to:

androstenediol, androstenedione, dehydroepiandrosterone (DHEA),
dihydrotestosterone, testosterone and their analogues#.

Where a Prohibited Substance (as listed above) is capable of being produced by the
body naturally, a Sample will be deemed to contain such Prohibited Substance where the concentration of the Prohibited Substance or its metabolites or markers and/or any other relevant ratio(s) in the Athlete’s Sample so deviates from the range of values normally found in humans so as not to be consistent with normal endogenous production. A Sample shall not be deemed to contain a Prohibited Substance in any such case where the Athlete proves by evidence that the concentration of the Prohibited Substance or its metabolites or markers and/or the relevant ratio(s) in the Athlete’s Sample is attributable to a pathological or physiological condition. In all cases, and at any concentration, the laboratory will report an adverse finding if, based on any reliable analytical method, it can show that the Prohibited Substance is of exogenous origin. If the laboratory result is not conclusive and no concentration as referred to in the above paragraph is found, the relevant Anti-Doping Organization shall conduct a further investigation if there are serious indications, such as a comparison to reference steroid profiles, for a possible Use of a Prohibited Substance. If the laboratory has reported the presence of a T/E ratio greater than six (6) to one (1) in the urine, further investigation is obligatory in order to determine whether the ratio is due to a physiological or pathological condition. In both cases, the investigation will include a review of any previous tests, subsequent tests and/or results of endocrine investigations. If previous tests are not available, the Athlete shall undergo an endocrine investigation or be tested unannounced at least three times within a three month period. Failure of the Athlete to co-operate in the investigations will result in considering the Athlete’s Sample to contain a Prohibited Substance.
2. Other Anabolic Agents
Clenbuterol, zeranol.

For purposes of this section:
* “exogenous” refers to a substance which is not capable of being produced by the body naturally. ** “endogenous” refers to a substance which is capable of being produced by the body naturally. # an "analogue" is defined as "a substance derived from the modification or alteration of the chemical structure of another substance while retaining a similar pharmacological effect.”
S5. PEPTIDE HORMONES

The following substances are prohibited, including their mimetics*, analogues# and
releasing factors:
1. Erythropoietin (EPO)
2. Growth hormone (hGH) and Insulin-like Growth Factor (IGF-1)
3. Chorionic Gonadotrophin (hCG) prohibited in males only;
4. Pituitary and synthetic gonadotrophins (LH) prohibited in males only;
5. Insulin.
6. Corticotrophins
Unless the Athlete can demonstrate that the concentration was due to a physiological or pathological condition, a Sample will be deemed to contain a Prohibited Substance (as listed above) where the concentration of the Prohibited Substance or its metabolites and/or relevant ratios or markers in the Athlete’s Sample so exceeds the range of values normally found in humans so as not to be consistent with normal endogenous production. The presence of analogues, mimetics, diagnostic marker(s) or releasing factors of a hormone listed above or of any other finding which indicate(s) that the substance detected is not the naturally present hormone, will be reported as an adverse analytical finding. For purposes of this section: * a “mimetic” is defined as a substance with pharmacological effect similar to that of another substance, regardless of the fact that it has a different chemical structure. # an "analogue" is defined as "a substance derived from the modification or alteration of the chemical structure of another substance while retaining a similar pharmacological effect.” S6. BETA-2 AGONISTS

All beta-2 agonists including their D- and L- isomers are prohibited except that
formoterol, salbutamol, salmeterol and terbutaline are permitted by inhalation only
to prevent and/or treat asthma and exercise-induced asthma/broncho-constriction.
A medical notification in accordance with section 8 of the International Standard for Therapeutic Use Exemptions is required. Despite the granting of a TUE, when the Laboratory has reported a concentration of salbutamol (free plus glucuronide) greater than 1000 ng/mL, this will be considered as an adverse analytical finding unless the athlete proves that the abnormal result was the consequence of the therapeutic use of inhaled salbutamol.

S7. AGENTS WITH ANTI-OESTROGENIC ACTIVITY
Aromatase inhibitors, clomiphene, cyclofenil, tamoxifen are prohibited only in
males.
S8. MASKING AGENTS
Masking agents are prohibited. They are products that have the potential to impair the excretion of Prohibited Substances, to conceal their presence in urine or other
Samples used in doping control, or to change haematological parameters.
Masking agents include but are not limited to:
Diuretics*, epitestosterone, probenecid, plasma expanders (e.g. dextran,
hydroxyethyl starch.)

*A medical approval in accordance with section 7 of the International Standard for
Therapeutic Use Exemptions is not valid if an Athlete’s urine contains a diuretic in
association with threshold or sub-threshold levels of a Prohibited Substance(s).
Diuretics include :
acetazolamide, amiloride, bumetanide, canrenone, chlortalidone, etacrynic
acid, furosemide, indapamide, mersalyl, spironolactone, thiazides (e.g.
bendroflumethiazide, chlorothiazide, hydrochlorothiazide) and
triamterene, and other substances with similar chemical structure or similar
pharmacological effects.

S.9 GLUCOCORTICOSTEROIDS
Glucocorticosteroids are prohibited when administered orally, rectally, or by
intravenous or intramuscular administration. All other administration routes require a medical notification in accordance with section 8 of the International Standard for Therapeutic Use Exemptions. PROHIBITED METHODS

M1. ENHANCEMENT OF OXYGEN TRANSFER

The following are prohibited:

a.
Blood doping. Blood doping is the use of autologous, homologous or heterologous blood or red blood cell products of any origin, other than for legitimate medical treatment. The Use of products that enhance the uptake, transport or delivery of oxygen, e.g. erythropoietins, modified haemoglobin products including but not limited to haemoglobin-based blood substitutes, microencapsulated haemoglobin products, perfluorochemicals, and efaproxiral (RSR13).
M2. PHARMACOLOGICAL, CHEMICAL AND PHYSICAL MANIPULATION
Pharmacological, chemical and physical manipulation is the Use of substances and methods, including masking agents, which alter, attempt to alter or may reasonably be expected to alter the integrity and validity of specimens collected in doping controls. These include but are not limited to catheterisation, urine substitution and/or tampering, inhibition of renal excretion and alterations of testosterone and epitestosterone concentrations.
M3. GENE DOPING
Gene or cell doping is defined as the non-therapeutic use of genes, genetic elements and/or cells that have the capacity to enhance athletic performance. SUBSTANCES AND METHODS
PROHIBITED IN- AND OUT-OF-COMPETITION
PROHIBITED SUBSTANCES

(All categories listed hereunder refer to all those substances and methods S4. ANABOLIC AGENTS
S5. PEPTIDE HORMONES
S6. BETA-2 AGONISTS*
S7. AGENTS WITH ANTI-OESTROGENIC ACTIVITY
S8. MASKING AGENTS
(*Only clenbuterol, and salbutamol when its concentration in urine is greater than

PROHIBITED METHODS

M1. ENHANCEMENT OF OXYGEN TRANSFER
M2. PHARMACOLOGICAL, CHEMICAL AND PHYSICAL
MANIPULATION
M3. GENE DOPING
SUBSTANCES PROHIBITED IN PARTICULAR SPORTS

P.1 ALCOHOL
Alcohol (ethanol) is prohibited in-Competition only, in the following sports. Detection will be conducted by breath analysis and/or blood. The doping violation threshold for each Federation is reported in parenthesis. If no threshold is indicated, the presence of any quantity of alcohol shall constitute a doping violation. Aeronautic (FAI) (0.10 g/L) for the modern pentathlon discipline Wrestling (FILA)
P.2 BETA-BLOCKERS
Unless otherwise specified, beta-blockers are prohibited in-Competition only, in the following sports. Aeronautic (FAI) Archery (FITA) (also prohibited out of competition) Automobile (FIA) Billiards (WCBS) Bobsleigh (FIBT) Boules (CMSB) Bridge (FMB) Chess (FIDE) Curling (WCF) Football (FIFA) Gymnastics (FIG) Motorcycling (FIM) Modern Pentathlon (UIPM) for the modern pentathlon discipline Nine-pin bowling (FIQ) Sailing (ISAF) match race helms only
Shooting (ISSF) (also prohibited out of competition)
Skiing (FIS) ski jumping & free style snow board
Swimming (FINA) in diving & synchronised swimming
Wrestling (FILA)
Beta-blockers include, but are not limited to, the following:
acebutolol, alprenolol, atenolol, betaxolol, bisoprolol, bunolol, carteolol,
carvedilol, celiprolol, esmolol, labetalol, levobunolol, metipranolol,
metoprolol, nadolol, oxprenolol, pindolol, propranolol, sotalol, timolol.
P.3 DIURETICS
Diuretics are prohibited in- and out- of competition in all sports as masking agents. However, in the following weight-classified sports and sports where weight loss can enhance performance, no Therapeutic Use Exemptions shall be granted for use of diuretics. Body-Building (IFBB) Boxing (AIBA) Judo (IJF) Karate (WKF) Powerlifting (IPF) Rowing (Light-Weight) (FISA) Skiing (FIS) for Ski Jumping only Taekwondo (WTF) Weightlifting (IWF)
Wrestling (FILA)
Wushu (IWUF)


SPECIFIED SUBSTANCES*


“Specified Substances” are listed below:
Stimulants: ephedrine, L-methylamphetamine, methylephedrine.
Cannabinoids.
Inhaled Beta-2 Agonists (except clenbuterol). Diuretics (this does not apply to section P3). Masking Agents: probenecid. Glucocorticosteroids Beta Blockers Alcohol *; The WADA Code (10.3) states “The Prohibited List may identify specified substances which are particularly susceptible to unintentional anti-doping rule violations because of their general availability in medicinal products or which are less likely to be successfully abused as doping agents.” A doping violation involving such substances may result in a reduced sanction as noted in the Code provided that the “…Athlete can establish that the Use of such a specified substance was not intended to enhance sport performance…”

Source: http://www.cstps.cz/old2005/atheny/zl.pdf